These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 38944367)

  • 21. Circadian rhythm alterations affecting the pathology of neurodegenerative diseases.
    Canever JB; Queiroz LY; Soares ES; de Avelar NCP; Cimarosti HI
    J Neurochem; 2023 Jun; ():. PubMed ID: 37358003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abnormal Mitochondrial Quality Control in Neurodegenerative Diseases.
    Yan X; Wang B; Hu Y; Wang S; Zhang X
    Front Cell Neurosci; 2020; 14():138. PubMed ID: 32655368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitochondrial Dysfunction as a Signaling Target for Therapeutic Intervention in Major Neurodegenerative Disease.
    Mangrulkar SV; Wankhede NL; Kale MB; Upaganlawar AB; Taksande BG; Umekar MJ; Anwer MK; Dailah HG; Mohan S; Behl T
    Neurotox Res; 2023 Dec; 41(6):708-729. PubMed ID: 37162686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurodegeneration as a consequence of failed mitochondrial maintenance.
    Karbowski M; Neutzner A
    Acta Neuropathol; 2012 Feb; 123(2):157-71. PubMed ID: 22143516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Multifaceted Role of Cofilin in Neurodegeneration and Stroke: Insights into Pathogenesis and Targeting as a Therapy.
    Shehjar F; Almarghalani DA; Mahajan R; Hasan SA; Shah ZA
    Cells; 2024 Jan; 13(2):. PubMed ID: 38247879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitochondrial quality control: Epigenetic signatures and therapeutic strategies.
    Ambekar T; Pawar J; Rathod R; Patel M; Fernandes V; Kumar R; Singh SB; Khatri DK
    Neurochem Int; 2021 Sep; 148():105095. PubMed ID: 34111479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of neuronal bioenergetics as a therapeutic strategy in neurodegenerative diseases.
    Onyango IG; Bennett JP; Stokin GB
    Neural Regen Res; 2021 Aug; 16(8):1467-1482. PubMed ID: 33433460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitochondria in neurodegeneration.
    Chu CT
    Curr Opin Physiol; 2022 Apr; 26():. PubMed ID: 35814636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitophagy regulation in aging and neurodegenerative disease.
    Banarase TA; Sammeta SS; Wankhede NL; Mangrulkar SV; Rahangdale SR; Aglawe MM; Taksande BG; Upaganlawar AB; Umekar MJ; Kale MB
    Biophys Rev; 2023 Apr; 15(2):239-255. PubMed ID: 37124925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alleviating Neurodegenerative Diseases Associated with Mitochondrial Defects by Therapeutic Biomolecules.
    Roy T; Padhi S; Mazumder R; Majee C; Das S; Monika M; Mishra R; Kapoor B
    Curr Top Med Chem; 2024 Apr; ():. PubMed ID: 38591201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crosstalk between mitochondrial dysfunction, oxidative stress, and age related neurodegenerative disease: Etiologies and therapeutic strategies.
    Elfawy HA; Das B
    Life Sci; 2019 Feb; 218():165-184. PubMed ID: 30578866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The multi-faceted role of mitochondria in the pathology of Parkinson's disease.
    Trinh D; Israwi AR; Arathoon LR; Gleave JA; Nash JE
    J Neurochem; 2021 Mar; 156(6):715-752. PubMed ID: 33616931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mitochondria as a therapeutic target for aging and neurodegenerative diseases.
    Reddy PH; Reddy TP
    Curr Alzheimer Res; 2011 Jun; 8(4):393-409. PubMed ID: 21470101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of Mitophagy in neurodegenerative Diseases and potential tagarts for Therapy.
    Jiao L; Du X; Li Y; Jiao Q; Jiang H
    Mol Biol Rep; 2022 Nov; 49(11):10749-10760. PubMed ID: 35794507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autophagy and Mitochondria: Targets in Neurodegenerative Disorders.
    Kumar A; Dhawan A; Kadam A; Shinde A
    CNS Neurol Disord Drug Targets; 2018; 17(9):696-705. PubMed ID: 30113005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
    Sas K; Robotka H; Toldi J; Vécsei L
    J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mitophagy Regulates Neurodegenerative Diseases.
    Cen X; Zhang M; Zhou M; Ye L; Xia H
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autophagy of mitochondria: a promising therapeutic target for neurodegenerative disease.
    Kamat PK; Kalani A; Kyles P; Tyagi SC; Tyagi N
    Cell Biochem Biophys; 2014 Nov; 70(2):707-19. PubMed ID: 24807843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Power Failure of Mitochondria and Oxidative Stress in Neurodegeneration and Its Computational Models.
    Woo J; Cho H; Seol Y; Kim SH; Park C; Yousefian-Jazi A; Hyeon SJ; Lee J; Ryu H
    Antioxidants (Basel); 2021 Feb; 10(2):. PubMed ID: 33546471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitochondrial dysfunction in neurodegenerative disorders.
    Klemmensen MM; Borrowman SH; Pearce C; Pyles B; Chandra B
    Neurotherapeutics; 2024 Jan; 21(1):e00292. PubMed ID: 38241161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.